UnknownNot Applicable

A Registry for Patients With Systemic Mastocytosis in China

China150 participantsStarted 2023-09-01

Plain-language summary

The Registry for Patients With Systemic Mastocytosis in China is a voluntary, observational database that will capture demographic, socioeconomic, and disease information with systemic mastocytosis. No experimental intervention is involved.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: 1\. Any patient with a diagnosis of systemic mastocytosis according to World Health Organization (WHO) classification, including subtypes of SM, who is willing and able to provide written online informed consent. Exclusion Criteria: None

What they're measuring

The morbidity rate over 2 years ofSystemic Mastocytosis and its subtypes (cases per 1,000 individuals per year)

Timeframe: at 2 year

Trial details

NCT IDNCT06013683

SponsorThe First Affiliated Hospital of Soochow University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-31

Contact for this trial

Suning Chen, Professor

+86-13814881746 chensuning@sina.com

View on ClinicalTrials.gov More Systemic Mastocytoses trials